This Week Last Year in Medtech: April 30 – May 6
See what Zimmer Biomet, GE Healthcare, and Abbott were up to this time last year.
Beta Bionics Shines with iLet Bionic Pancreas Data
The firm’s data show iLet reduced HbA1c and improved time in range vs. standard of care for a diverse range of people with type 1 diabetes.
Can Point-of-Care Diagnostics Help with HIV Challenges?
More advanced therapies are needed in the fight against HIV infections.
Biomerics Expands Image Guided Intervention Position
The company has created an Image-Guided Intervention division.
Zimmer Biomet Beats Analyst Expectations in Q1
Strong procedure volume recovery drove underlying growth, but headwinds cloud Zimmer Biomet's forecast.
Online Learning Platform Enhances Diagnostic Accuracy
2D and 3D mammography gets a boost through partnership with DetectEDX and GE Healthcare.
Abbott’s New Clearance Addresses Rise in Sexually Transmitted Infections
The Abbott Park, IL-based company can now detect four common sexually transmitted infections with the Alinity m assay.
Why You Should Embrace Direct-to-Consumer Lab Testing
Why more patients are choosing direct-to-consumer lab testing, and why labs should embrace the shift as well.
Insulet Set to Have a Major Leadership Change in June
The Acton, MA-based company’s President and CEO, Shacey Petrovic is stepping down next month and a high-level executive from ResMed will take the helm.
Challenging the Criteria for Whole Genome Sequencing in Children
The study is expected to answer questions about pediatric diagnosis and efficacy among critically ill kids.
About the Author(s)
You May Also Like